nodes	percent_of_prediction	percent_of_DWPC	metapath
Brimonidine—Clonidine—CYP1A1—kidney cancer	0.00265	0.653	CrCbGaD
Brimonidine—AOX1—nephron tubule—kidney cancer	0.00246	0.107	CbGeAlD
Brimonidine—AOX1—renal system—kidney cancer	0.00223	0.0973	CbGeAlD
Brimonidine—AOX1—kidney—kidney cancer	0.00216	0.094	CbGeAlD
Brimonidine—AOX1—cortex of kidney—kidney cancer	0.0021	0.0916	CbGeAlD
Brimonidine—AOX1—gonad—kidney cancer	0.002	0.0872	CbGeAlD
Brimonidine—AOX1—cardiac atrium—kidney cancer	0.002	0.0871	CbGeAlD
Brimonidine—ADRA2C—nephron tubule—kidney cancer	0.00155	0.0676	CbGeAlD
Brimonidine—ADRA2C—renal system—kidney cancer	0.00141	0.0615	CbGeAlD
Brimonidine—Clonidine—ABCB1—kidney cancer	0.00141	0.347	CrCbGaD
Brimonidine—ADRA2C—kidney—kidney cancer	0.00137	0.0594	CbGeAlD
Brimonidine—ADRA2C—cortex of kidney—kidney cancer	0.00133	0.0579	CbGeAlD
Brimonidine—ADRA2C—cardiac atrium—kidney cancer	0.00126	0.0551	CbGeAlD
Brimonidine—ADRA2A—cortex of kidney—kidney cancer	0.00106	0.0462	CbGeAlD
Brimonidine—ADRA2A—gonad—kidney cancer	0.00101	0.044	CbGeAlD
Brimonidine—ADRA2A—cardiac atrium—kidney cancer	0.00101	0.0439	CbGeAlD
Brimonidine—Dyspepsia—Sunitinib—kidney cancer	0.000944	0.00097	CcSEcCtD
Brimonidine—Cardiac disorder—Paclitaxel—kidney cancer	0.000941	0.000967	CcSEcCtD
Brimonidine—Flushing—Paclitaxel—kidney cancer	0.000941	0.000967	CcSEcCtD
Brimonidine—Abnormal vision—Doxorubicin—kidney cancer	0.000931	0.000957	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000926	0.000951	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000925	0.00095	CcSEcCtD
Brimonidine—Asthenia—Vinblastine—kidney cancer	0.000924	0.00095	CcSEcCtD
Brimonidine—Fatigue—Sunitinib—kidney cancer	0.000924	0.00095	CcSEcCtD
Brimonidine—Depression—Capecitabine—kidney cancer	0.000924	0.00095	CcSEcCtD
Brimonidine—Asthenia—Everolimus—kidney cancer	0.000921	0.000946	CcSEcCtD
Brimonidine—Cough—Gemcitabine—kidney cancer	0.00092	0.000945	CcSEcCtD
Brimonidine—Angiopathy—Paclitaxel—kidney cancer	0.00092	0.000945	CcSEcCtD
Brimonidine—Pain—Sunitinib—kidney cancer	0.000917	0.000942	CcSEcCtD
Brimonidine—Immune system disorder—Paclitaxel—kidney cancer	0.000916	0.000941	CcSEcCtD
Brimonidine—Mediastinal disorder—Paclitaxel—kidney cancer	0.000914	0.000939	CcSEcCtD
Brimonidine—Hypertension—Gemcitabine—kidney cancer	0.00091	0.000935	CcSEcCtD
Brimonidine—Pruritus—Everolimus—kidney cancer	0.000908	0.000933	CcSEcCtD
Brimonidine—Oedema—Vincristine—kidney cancer	0.000907	0.000932	CcSEcCtD
Brimonidine—Arrhythmia—Paclitaxel—kidney cancer	0.000906	0.000931	CcSEcCtD
Brimonidine—Infection—Vincristine—kidney cancer	0.000901	0.000926	CcSEcCtD
Brimonidine—Conjunctivitis—Capecitabine—kidney cancer	0.000901	0.000926	CcSEcCtD
Brimonidine—Chest pain—Gemcitabine—kidney cancer	0.000897	0.000922	CcSEcCtD
Brimonidine—Arthralgia—Gemcitabine—kidney cancer	0.000897	0.000922	CcSEcCtD
Brimonidine—Myalgia—Gemcitabine—kidney cancer	0.000897	0.000922	CcSEcCtD
Brimonidine—Diabetes mellitus—Doxorubicin—kidney cancer	0.000891	0.000916	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000891	0.000916	CcSEcCtD
Brimonidine—Nervous system disorder—Vincristine—kidney cancer	0.000889	0.000914	CcSEcCtD
Brimonidine—Asthenia—Erlotinib—kidney cancer	0.000889	0.000913	CcSEcCtD
Brimonidine—Mental disorder—Paclitaxel—kidney cancer	0.000888	0.000913	CcSEcCtD
Brimonidine—Discomfort—Gemcitabine—kidney cancer	0.000887	0.000911	CcSEcCtD
Brimonidine—Erythema—Paclitaxel—kidney cancer	0.000882	0.000907	CcSEcCtD
Brimonidine—Pruritus—Erlotinib—kidney cancer	0.000876	0.000901	CcSEcCtD
Brimonidine—Fatigue—Dactinomycin—kidney cancer	0.000875	0.000899	CcSEcCtD
Brimonidine—Pain—Dactinomycin—kidney cancer	0.000868	0.000892	CcSEcCtD
Brimonidine—Dysgeusia—Paclitaxel—kidney cancer	0.000864	0.000888	CcSEcCtD
Brimonidine—Oedema—Gemcitabine—kidney cancer	0.00086	0.000884	CcSEcCtD
Brimonidine—Eye pain—Doxorubicin—kidney cancer	0.000859	0.000882	CcSEcCtD
Brimonidine—Infection—Gemcitabine—kidney cancer	0.000855	0.000878	CcSEcCtD
Brimonidine—Dizziness—Vinblastine—kidney cancer	0.000852	0.000876	CcSEcCtD
Brimonidine—Dizziness—Everolimus—kidney cancer	0.000849	0.000872	CcSEcCtD
Brimonidine—Hypotension—Vincristine—kidney cancer	0.000847	0.000871	CcSEcCtD
Brimonidine—Bradycardia—Capecitabine—kidney cancer	0.000847	0.00087	CcSEcCtD
Brimonidine—Nervous system disorder—Gemcitabine—kidney cancer	0.000844	0.000867	CcSEcCtD
Brimonidine—Skin disorder—Gemcitabine—kidney cancer	0.000836	0.000859	CcSEcCtD
Brimonidine—Rhinitis—Capecitabine—kidney cancer	0.000834	0.000857	CcSEcCtD
Brimonidine—Vision blurred—Paclitaxel—kidney cancer	0.000832	0.000855	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000826	0.000849	CcSEcCtD
Brimonidine—Pharyngitis—Capecitabine—kidney cancer	0.000826	0.000849	CcSEcCtD
Brimonidine—Hypersensitivity—Sorafenib—kidney cancer	0.000821	0.000844	CcSEcCtD
Brimonidine—Insomnia—Vincristine—kidney cancer	0.00082	0.000843	CcSEcCtD
Brimonidine—Dizziness—Erlotinib—kidney cancer	0.000819	0.000842	CcSEcCtD
Brimonidine—Paraesthesia—Vincristine—kidney cancer	0.000814	0.000837	CcSEcCtD
Brimonidine—Rash—Everolimus—kidney cancer	0.000809	0.000832	CcSEcCtD
Brimonidine—Dermatitis—Everolimus—kidney cancer	0.000809	0.000831	CcSEcCtD
Brimonidine—Headache—Vinblastine—kidney cancer	0.000807	0.00083	CcSEcCtD
Brimonidine—Headache—Everolimus—kidney cancer	0.000804	0.000826	CcSEcCtD
Brimonidine—Hypotension—Gemcitabine—kidney cancer	0.000804	0.000826	CcSEcCtD
Brimonidine—Visual impairment—Capecitabine—kidney cancer	0.000802	0.000824	CcSEcCtD
Brimonidine—Asthenia—Sorafenib—kidney cancer	0.000799	0.000822	CcSEcCtD
Brimonidine—Syncope—Paclitaxel—kidney cancer	0.000791	0.000813	CcSEcCtD
Brimonidine—Lethargy—Doxorubicin—kidney cancer	0.000791	0.000813	CcSEcCtD
Brimonidine—Hypersensitivity—Sunitinib—kidney cancer	0.00079	0.000812	CcSEcCtD
Brimonidine—Pruritus—Sorafenib—kidney cancer	0.000788	0.00081	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000784	0.000805	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Vincristine—kidney cancer	0.000783	0.000805	CcSEcCtD
Brimonidine—Fatigue—Vincristine—kidney cancer	0.000782	0.000803	CcSEcCtD
Brimonidine—Rash—Erlotinib—kidney cancer	0.000781	0.000803	CcSEcCtD
Brimonidine—Dermatitis—Erlotinib—kidney cancer	0.00078	0.000802	CcSEcCtD
Brimonidine—Palpitations—Paclitaxel—kidney cancer	0.00078	0.000801	CcSEcCtD
Brimonidine—Insomnia—Gemcitabine—kidney cancer	0.000778	0.0008	CcSEcCtD
Brimonidine—Eye disorder—Capecitabine—kidney cancer	0.000777	0.000799	CcSEcCtD
Brimonidine—Headache—Erlotinib—kidney cancer	0.000776	0.000797	CcSEcCtD
Brimonidine—Loss of consciousness—Paclitaxel—kidney cancer	0.000776	0.000797	CcSEcCtD
Brimonidine—Pain—Vincristine—kidney cancer	0.000775	0.000797	CcSEcCtD
Brimonidine—Osteoarthritis—Doxorubicin—kidney cancer	0.000775	0.000797	CcSEcCtD
Brimonidine—Paraesthesia—Gemcitabine—kidney cancer	0.000772	0.000794	CcSEcCtD
Brimonidine—Flushing—Capecitabine—kidney cancer	0.000772	0.000794	CcSEcCtD
Brimonidine—Cardiac disorder—Capecitabine—kidney cancer	0.000772	0.000794	CcSEcCtD
Brimonidine—Cough—Paclitaxel—kidney cancer	0.00077	0.000791	CcSEcCtD
Brimonidine—Asthenia—Sunitinib—kidney cancer	0.000769	0.000791	CcSEcCtD
Brimonidine—Dyspnoea—Gemcitabine—kidney cancer	0.000767	0.000788	CcSEcCtD
Brimonidine—Nausea—Vinblastine—kidney cancer	0.000765	0.000787	CcSEcCtD
Brimonidine—Somnolence—Gemcitabine—kidney cancer	0.000765	0.000786	CcSEcCtD
Brimonidine—Nausea—Everolimus—kidney cancer	0.000762	0.000784	CcSEcCtD
Brimonidine—Hypertension—Paclitaxel—kidney cancer	0.000762	0.000783	CcSEcCtD
Brimonidine—Pruritus—Sunitinib—kidney cancer	0.000758	0.00078	CcSEcCtD
Brimonidine—Angiopathy—Capecitabine—kidney cancer	0.000755	0.000776	CcSEcCtD
Brimonidine—Immune system disorder—Capecitabine—kidney cancer	0.000751	0.000772	CcSEcCtD
Brimonidine—Arthralgia—Paclitaxel—kidney cancer	0.000751	0.000772	CcSEcCtD
Brimonidine—Myalgia—Paclitaxel—kidney cancer	0.000751	0.000772	CcSEcCtD
Brimonidine—Chest pain—Paclitaxel—kidney cancer	0.000751	0.000772	CcSEcCtD
Brimonidine—Mediastinal disorder—Capecitabine—kidney cancer	0.00075	0.000771	CcSEcCtD
Brimonidine—Anxiety—Paclitaxel—kidney cancer	0.000749	0.000769	CcSEcCtD
Brimonidine—Face oedema—Doxorubicin—kidney cancer	0.000748	0.000769	CcSEcCtD
Brimonidine—Hypersensitivity—Dactinomycin—kidney cancer	0.000748	0.000769	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000746	0.000767	CcSEcCtD
Brimonidine—Arrhythmia—Capecitabine—kidney cancer	0.000743	0.000764	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000743	0.000763	CcSEcCtD
Brimonidine—Discomfort—Paclitaxel—kidney cancer	0.000742	0.000763	CcSEcCtD
Brimonidine—Fatigue—Gemcitabine—kidney cancer	0.000742	0.000762	CcSEcCtD
Brimonidine—Dizziness—Sorafenib—kidney cancer	0.000737	0.000757	CcSEcCtD
Brimonidine—Pain—Gemcitabine—kidney cancer	0.000736	0.000756	CcSEcCtD
Brimonidine—Nausea—Erlotinib—kidney cancer	0.000736	0.000756	CcSEcCtD
Brimonidine—Dry mouth—Paclitaxel—kidney cancer	0.000735	0.000755	CcSEcCtD
Brimonidine—Mental disorder—Capecitabine—kidney cancer	0.000729	0.000749	CcSEcCtD
Brimonidine—Asthenia—Dactinomycin—kidney cancer	0.000728	0.000748	CcSEcCtD
Brimonidine—Erythema—Capecitabine—kidney cancer	0.000724	0.000744	CcSEcCtD
Brimonidine—Oedema—Paclitaxel—kidney cancer	0.00072	0.00074	CcSEcCtD
Brimonidine—Infection—Paclitaxel—kidney cancer	0.000716	0.000735	CcSEcCtD
Brimonidine—Dry skin—Doxorubicin—kidney cancer	0.000711	0.00073	CcSEcCtD
Brimonidine—Dysgeusia—Capecitabine—kidney cancer	0.000709	0.000729	CcSEcCtD
Brimonidine—Dizziness—Sunitinib—kidney cancer	0.000709	0.000729	CcSEcCtD
Brimonidine—Shock—Paclitaxel—kidney cancer	0.000709	0.000728	CcSEcCtD
Brimonidine—Nervous system disorder—Paclitaxel—kidney cancer	0.000706	0.000726	CcSEcCtD
Brimonidine—Tachycardia—Paclitaxel—kidney cancer	0.000703	0.000722	CcSEcCtD
Brimonidine—Rash—Sorafenib—kidney cancer	0.000702	0.000722	CcSEcCtD
Brimonidine—Dermatitis—Sorafenib—kidney cancer	0.000702	0.000721	CcSEcCtD
Brimonidine—Skin disorder—Paclitaxel—kidney cancer	0.0007	0.000719	CcSEcCtD
Brimonidine—Headache—Sorafenib—kidney cancer	0.000698	0.000717	CcSEcCtD
Brimonidine—Nasopharyngitis—Doxorubicin—kidney cancer	0.000693	0.000712	CcSEcCtD
Brimonidine—Vision blurred—Capecitabine—kidney cancer	0.000682	0.000701	CcSEcCtD
Brimonidine—Rash—Sunitinib—kidney cancer	0.000676	0.000695	CcSEcCtD
Brimonidine—Dermatitis—Sunitinib—kidney cancer	0.000675	0.000694	CcSEcCtD
Brimonidine—Hypotension—Paclitaxel—kidney cancer	0.000673	0.000692	CcSEcCtD
Brimonidine—Headache—Sunitinib—kidney cancer	0.000672	0.00069	CcSEcCtD
Brimonidine—Influenza—Doxorubicin—kidney cancer	0.00067	0.000689	CcSEcCtD
Brimonidine—Hypersensitivity—Vincristine—kidney cancer	0.000668	0.000687	CcSEcCtD
Brimonidine—Nausea—Sorafenib—kidney cancer	0.000662	0.00068	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000656	0.000674	CcSEcCtD
Brimonidine—Insomnia—Paclitaxel—kidney cancer	0.000651	0.000669	CcSEcCtD
Brimonidine—Asthenia—Vincristine—kidney cancer	0.000651	0.000669	CcSEcCtD
Brimonidine—Syncope—Capecitabine—kidney cancer	0.000649	0.000667	CcSEcCtD
Brimonidine—Paraesthesia—Paclitaxel—kidney cancer	0.000647	0.000665	CcSEcCtD
Brimonidine—Bronchitis—Doxorubicin—kidney cancer	0.000644	0.000662	CcSEcCtD
Brimonidine—Dyspnoea—Paclitaxel—kidney cancer	0.000642	0.00066	CcSEcCtD
Brimonidine—Somnolence—Paclitaxel—kidney cancer	0.00064	0.000658	CcSEcCtD
Brimonidine—Palpitations—Capecitabine—kidney cancer	0.00064	0.000658	CcSEcCtD
Brimonidine—Rash—Dactinomycin—kidney cancer	0.00064	0.000658	CcSEcCtD
Brimonidine—Nausea—Sunitinib—kidney cancer	0.000637	0.000654	CcSEcCtD
Brimonidine—Loss of consciousness—Capecitabine—kidney cancer	0.000636	0.000654	CcSEcCtD
Brimonidine—Dyspepsia—Paclitaxel—kidney cancer	0.000634	0.000652	CcSEcCtD
Brimonidine—Cough—Capecitabine—kidney cancer	0.000632	0.000649	CcSEcCtD
Brimonidine—Hypertension—Capecitabine—kidney cancer	0.000625	0.000643	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000622	0.000639	CcSEcCtD
Brimonidine—Fatigue—Paclitaxel—kidney cancer	0.000621	0.000638	CcSEcCtD
Brimonidine—Asthenia—Gemcitabine—kidney cancer	0.000617	0.000634	CcSEcCtD
Brimonidine—Arthralgia—Capecitabine—kidney cancer	0.000617	0.000634	CcSEcCtD
Brimonidine—Chest pain—Capecitabine—kidney cancer	0.000617	0.000634	CcSEcCtD
Brimonidine—Myalgia—Capecitabine—kidney cancer	0.000617	0.000634	CcSEcCtD
Brimonidine—Pain—Paclitaxel—kidney cancer	0.000616	0.000633	CcSEcCtD
Brimonidine—Anxiety—Capecitabine—kidney cancer	0.000614	0.000631	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000612	0.000629	CcSEcCtD
Brimonidine—Discomfort—Capecitabine—kidney cancer	0.000609	0.000626	CcSEcCtD
Brimonidine—Pruritus—Gemcitabine—kidney cancer	0.000609	0.000625	CcSEcCtD
Brimonidine—Dry mouth—Capecitabine—kidney cancer	0.000603	0.00062	CcSEcCtD
Brimonidine—Nausea—Dactinomycin—kidney cancer	0.000603	0.00062	CcSEcCtD
Brimonidine—Dizziness—Vincristine—kidney cancer	0.0006	0.000616	CcSEcCtD
Brimonidine—Drowsiness—Doxorubicin—kidney cancer	0.000597	0.000614	CcSEcCtD
Brimonidine—Oedema—Capecitabine—kidney cancer	0.000591	0.000607	CcSEcCtD
Brimonidine—Infection—Capecitabine—kidney cancer	0.000587	0.000603	CcSEcCtD
Brimonidine—Shock—Capecitabine—kidney cancer	0.000581	0.000598	CcSEcCtD
Brimonidine—Conjunctivitis—Doxorubicin—kidney cancer	0.000581	0.000597	CcSEcCtD
Brimonidine—Nervous system disorder—Capecitabine—kidney cancer	0.00058	0.000596	CcSEcCtD
Brimonidine—Tachycardia—Capecitabine—kidney cancer	0.000577	0.000593	CcSEcCtD
Brimonidine—Skin disorder—Capecitabine—kidney cancer	0.000574	0.00059	CcSEcCtD
Brimonidine—Rash—Vincristine—kidney cancer	0.000572	0.000588	CcSEcCtD
Brimonidine—Dermatitis—Vincristine—kidney cancer	0.000571	0.000587	CcSEcCtD
Brimonidine—Headache—Vincristine—kidney cancer	0.000568	0.000584	CcSEcCtD
Brimonidine—Sinusitis—Doxorubicin—kidney cancer	0.00056	0.000576	CcSEcCtD
Brimonidine—Hypotension—Capecitabine—kidney cancer	0.000552	0.000568	CcSEcCtD
Brimonidine—Bradycardia—Doxorubicin—kidney cancer	0.000546	0.000561	CcSEcCtD
Brimonidine—Rash—Gemcitabine—kidney cancer	0.000542	0.000557	CcSEcCtD
Brimonidine—Dermatitis—Gemcitabine—kidney cancer	0.000542	0.000557	CcSEcCtD
Brimonidine—Headache—Gemcitabine—kidney cancer	0.000539	0.000554	CcSEcCtD
Brimonidine—Nausea—Vincristine—kidney cancer	0.000539	0.000554	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000538	0.000553	CcSEcCtD
Brimonidine—Rhinitis—Doxorubicin—kidney cancer	0.000538	0.000553	CcSEcCtD
Brimonidine—Insomnia—Capecitabine—kidney cancer	0.000535	0.000549	CcSEcCtD
Brimonidine—Pharyngitis—Doxorubicin—kidney cancer	0.000532	0.000547	CcSEcCtD
Brimonidine—Paraesthesia—Capecitabine—kidney cancer	0.000531	0.000545	CcSEcCtD
Brimonidine—Hypersensitivity—Paclitaxel—kidney cancer	0.000531	0.000545	CcSEcCtD
Brimonidine—Dyspnoea—Capecitabine—kidney cancer	0.000527	0.000542	CcSEcCtD
Brimonidine—Dyspepsia—Capecitabine—kidney cancer	0.00052	0.000535	CcSEcCtD
Brimonidine—Visual impairment—Doxorubicin—kidney cancer	0.000517	0.000531	CcSEcCtD
Brimonidine—Asthenia—Paclitaxel—kidney cancer	0.000517	0.000531	CcSEcCtD
Brimonidine—Nausea—Gemcitabine—kidney cancer	0.000511	0.000525	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00051	0.000524	CcSEcCtD
Brimonidine—Fatigue—Capecitabine—kidney cancer	0.00051	0.000524	CcSEcCtD
Brimonidine—Pruritus—Paclitaxel—kidney cancer	0.00051	0.000524	CcSEcCtD
Brimonidine—Pain—Capecitabine—kidney cancer	0.000505	0.000519	CcSEcCtD
Brimonidine—Eye disorder—Doxorubicin—kidney cancer	0.000501	0.000515	CcSEcCtD
Brimonidine—Cardiac disorder—Doxorubicin—kidney cancer	0.000498	0.000511	CcSEcCtD
Brimonidine—Flushing—Doxorubicin—kidney cancer	0.000498	0.000511	CcSEcCtD
Brimonidine—Angiopathy—Doxorubicin—kidney cancer	0.000487	0.0005	CcSEcCtD
Brimonidine—Immune system disorder—Doxorubicin—kidney cancer	0.000484	0.000498	CcSEcCtD
Brimonidine—Mediastinal disorder—Doxorubicin—kidney cancer	0.000483	0.000497	CcSEcCtD
Brimonidine—Arrhythmia—Doxorubicin—kidney cancer	0.000479	0.000492	CcSEcCtD
Brimonidine—Dizziness—Paclitaxel—kidney cancer	0.000476	0.000489	CcSEcCtD
Brimonidine—Mental disorder—Doxorubicin—kidney cancer	0.00047	0.000483	CcSEcCtD
Brimonidine—Erythema—Doxorubicin—kidney cancer	0.000467	0.00048	CcSEcCtD
Brimonidine—Dysgeusia—Doxorubicin—kidney cancer	0.000457	0.00047	CcSEcCtD
Brimonidine—Rash—Paclitaxel—kidney cancer	0.000454	0.000467	CcSEcCtD
Brimonidine—Dermatitis—Paclitaxel—kidney cancer	0.000454	0.000466	CcSEcCtD
Brimonidine—Headache—Paclitaxel—kidney cancer	0.000451	0.000464	CcSEcCtD
Brimonidine—Vision blurred—Doxorubicin—kidney cancer	0.00044	0.000452	CcSEcCtD
Brimonidine—Hypersensitivity—Capecitabine—kidney cancer	0.000435	0.000448	CcSEcCtD
Brimonidine—Nausea—Paclitaxel—kidney cancer	0.000428	0.00044	CcSEcCtD
Brimonidine—Asthenia—Capecitabine—kidney cancer	0.000424	0.000436	CcSEcCtD
Brimonidine—Syncope—Doxorubicin—kidney cancer	0.000419	0.00043	CcSEcCtD
Brimonidine—Pruritus—Capecitabine—kidney cancer	0.000418	0.00043	CcSEcCtD
Brimonidine—Palpitations—Doxorubicin—kidney cancer	0.000413	0.000424	CcSEcCtD
Brimonidine—Loss of consciousness—Doxorubicin—kidney cancer	0.00041	0.000422	CcSEcCtD
Brimonidine—Cough—Doxorubicin—kidney cancer	0.000407	0.000419	CcSEcCtD
Brimonidine—Hypertension—Doxorubicin—kidney cancer	0.000403	0.000414	CcSEcCtD
Brimonidine—Myalgia—Doxorubicin—kidney cancer	0.000397	0.000408	CcSEcCtD
Brimonidine—Arthralgia—Doxorubicin—kidney cancer	0.000397	0.000408	CcSEcCtD
Brimonidine—Chest pain—Doxorubicin—kidney cancer	0.000397	0.000408	CcSEcCtD
Brimonidine—Anxiety—Doxorubicin—kidney cancer	0.000396	0.000407	CcSEcCtD
Brimonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000395	0.000406	CcSEcCtD
Brimonidine—Discomfort—Doxorubicin—kidney cancer	0.000393	0.000404	CcSEcCtD
Brimonidine—Dizziness—Capecitabine—kidney cancer	0.000391	0.000402	CcSEcCtD
Brimonidine—Dry mouth—Doxorubicin—kidney cancer	0.000389	0.000399	CcSEcCtD
Brimonidine—Oedema—Doxorubicin—kidney cancer	0.000381	0.000392	CcSEcCtD
Brimonidine—Infection—Doxorubicin—kidney cancer	0.000378	0.000389	CcSEcCtD
Brimonidine—Shock—Doxorubicin—kidney cancer	0.000375	0.000385	CcSEcCtD
Brimonidine—Nervous system disorder—Doxorubicin—kidney cancer	0.000374	0.000384	CcSEcCtD
Brimonidine—Rash—Capecitabine—kidney cancer	0.000373	0.000383	CcSEcCtD
Brimonidine—Dermatitis—Capecitabine—kidney cancer	0.000372	0.000383	CcSEcCtD
Brimonidine—Tachycardia—Doxorubicin—kidney cancer	0.000372	0.000382	CcSEcCtD
Brimonidine—Headache—Capecitabine—kidney cancer	0.00037	0.000381	CcSEcCtD
Brimonidine—Skin disorder—Doxorubicin—kidney cancer	0.00037	0.00038	CcSEcCtD
Brimonidine—Hypotension—Doxorubicin—kidney cancer	0.000356	0.000366	CcSEcCtD
Brimonidine—Nausea—Capecitabine—kidney cancer	0.000351	0.000361	CcSEcCtD
Brimonidine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000347	0.000357	CcSEcCtD
Brimonidine—Insomnia—Doxorubicin—kidney cancer	0.000345	0.000354	CcSEcCtD
Brimonidine—Paraesthesia—Doxorubicin—kidney cancer	0.000342	0.000352	CcSEcCtD
Brimonidine—Dyspnoea—Doxorubicin—kidney cancer	0.00034	0.000349	CcSEcCtD
Brimonidine—Somnolence—Doxorubicin—kidney cancer	0.000339	0.000348	CcSEcCtD
Brimonidine—Dyspepsia—Doxorubicin—kidney cancer	0.000335	0.000345	CcSEcCtD
Brimonidine—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000329	0.000338	CcSEcCtD
Brimonidine—Fatigue—Doxorubicin—kidney cancer	0.000328	0.000338	CcSEcCtD
Brimonidine—Pain—Doxorubicin—kidney cancer	0.000326	0.000335	CcSEcCtD
Brimonidine—Hypersensitivity—Doxorubicin—kidney cancer	0.000281	0.000288	CcSEcCtD
Brimonidine—Asthenia—Doxorubicin—kidney cancer	0.000273	0.000281	CcSEcCtD
Brimonidine—Pruritus—Doxorubicin—kidney cancer	0.00027	0.000277	CcSEcCtD
Brimonidine—Dizziness—Doxorubicin—kidney cancer	0.000252	0.000259	CcSEcCtD
Brimonidine—Rash—Doxorubicin—kidney cancer	0.00024	0.000247	CcSEcCtD
Brimonidine—Dermatitis—Doxorubicin—kidney cancer	0.00024	0.000247	CcSEcCtD
Brimonidine—Headache—Doxorubicin—kidney cancer	0.000239	0.000245	CcSEcCtD
Brimonidine—Nausea—Doxorubicin—kidney cancer	0.000226	0.000233	CcSEcCtD
